The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

Moderna (MRNA) is scheduled to announce Q3 earnings results on November 6, before market open, with analysts’ consensus pointing to another quarter of losses. Analysts have projected a loss of -$2.16 ...

Messenger RNA (mRNA) therapeutics hold significant promise for the future of personalized cancer treatment, but persistent off-target effects and treatment-resistant tumor microenvironments have ...

The health impact of a Covid infection was higher than the risks from the vaccine for teens and children - but it won't ...

I know how destructive unchecked addiction can be. All the victims of the ongoing opioid crisis do, too. And this is about more than addiction — as when rare but real cases of myocarditis appeared in ...

What if the brain's response to stress could be read not in fleeting neurotransmitter bursts, but in the quieting of genes deep inside chromatin? Researchers at the University of Alabama at Birmingham ...

The reference to “genetic material” may lead to misconceptions, but mRNA does not enter the cell nucleus, where our DNA ...

PepGen shifts focus to PGN-EDODM1 for Myotonic Dystrophy Type 1 after discontinuing PGN-EDO51 for Duchenne Muscular Dystrophy ...

Victorian researchers have developed a world-first RNA drug for lupus, an auto-immune disease that affects around 20,000 ...

A biotech stock with strong FDA approval odds this November may see limited upside amid a full valuation and a pending lawsuit.